Cargando…
Efficacy of Low-Dose rhGM-CSF Treatment in a Patient With Severe Congenital Neutropenia Due to CSF3R Deficiency: Case Report of a Novel Biallelic CSF3R Mutation and Literature Review
This study reports the clinical manifestations, genetics, and efficacy of treatment with the efficacy of recombinant human granulocyte macrophage colony-stimulating factor (rhGM-GSF) of a 2-year-old female patient with severe congenital neutropenia (SCN) type 7 (SCN7) caused by novel biallelic mutat...
Autores principales: | Zhou, Junli, Sun, Chengjun, Huang, Honglin, Zhu, Qiguo, Wen, Fengyun, Dong, Ying, Wang, Hongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585998/ https://www.ncbi.nlm.nih.gov/pubmed/34778134 http://dx.doi.org/10.3389/fped.2021.746159 |
Ejemplares similares
-
rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.
por: Rampling, R., et al.
Publicado: (1994) -
Topically administered rhGM-CSF affects PPARβ expression in the stasis zone
por: Fu, Gen-Feng, et al.
Publicado: (2017) -
Tumor growth under rhGM-CSF application in an orthotopic rodent glioma model
por: Linsenmann, Thomas, et al.
Publicado: (2019) -
Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)
por: Gajewska, Marta E., et al.
Publicado: (2018) -
Bioavailability of Orally Administered rhGM-CSF: A Single-Dose, Randomized, Open-Label, Two-Period Crossover Trial
por: Zhang, Wenping, et al.
Publicado: (2009)